Doctor Kaspar Broch
Oslo University Hospital Rikshospitalet, Oslo (Norway)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Evolocumab for cardiac allograft vasculopathy
Event: ESC Congress 2023
Topic: Heart Transplantation
Session: New trials miscellany
Design of the trial DAPAgliflozin for Renal protection in Heart Transplant recipients (DAPARHT)
Event: Heart Failure 2023
Topic: Heart Transplantation
Session: Chronic heart failure - treatment 2
Soluble ST2 is strongly associated with outcomes in pulmonary arterial hypertension
Event: Heart Failure 2023
Topic: Pulmonary Hypertension
Session: Pulmonary circulation
Prevalence and prognostic implication of iron deficiency in patients with severe aortic stenosis
Event: Heart Failure 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Valvular Heart Disease – Epidemiology, Prognosis, Outcome
Right ventricular improvement parallels left ventricular improvement after introduction of therapy for dilated cardiomyopathy
Event: HEART FAILURE 2016
Topic: Right ventricular function
Session: Right ventricular function
Echocardiography predicts right ventricular size and function in patients with dilated cardiomyopathy: a comparison with magnetic resonance imaging
Event: HEART FAILURE 2016
Topic: Right ventricular function
Session: Right ventricular function
ESC 365 is supported by
